Key Takeaways
- • Bain Capital's $750 million debt refinancing for Vinarchy (the merged Accolade Wines and Pernod Ricard wine unit) has underperformed expectations, creating challenges for both Bain's special situations team and Commonwealth Bank of Australia, the sole underwriter on the deal.
- • The refinancing was structured as an asset-backed lending facility secured against debtors, bulk, and bottled inventory, with CBA seeking to syndicate two-thirds of the loan to other lenders and credit funds.
- • Bain acquired Accolade Wines via a debt-for-equity swap in 2024, with the subsequent refinancing pitch heavily reliant on demonstrating turnaround progress under the private equity firm's management.
- • Major lenders including Deutsche Bank and Apollo Global Management were approached to participate in the syndication, underscoring the deal's difficulty in attracting investor appetite.
Summary
The transaction was structured as an asset-backed lending facility, collateralized by debtors, bulk inventory, and bottled wine stock. CBA's syndication strategy called for selling down two-thirds of the loan exposure to institutional investors and credit funds, limiting the bank's direct exposure. The difficulty in placing this asset-backed facility reflects broader challenges in debt capital markets and investor caution regarding leveraged structures secured against wine industry assets.
The underperformance of this refinancing is particularly notable given that Bain's pitch to lenders explicitly emphasized operational improvements and turnaround metrics achieved post-acquisition. The involvement of major institutions such as Deutsche Bank and Apollo Global Management in the process indicates that prominent market participants conducted due diligence but ultimately chose not to commit capital at terms acceptable to the sponsor and arranging bank. This reluctance suggests either deteriorating fundamentals at the combined business or market-wide repricing of risk in the wine sector and asset-backed lending more broadly.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.